FUSED TRICYCLIC COMPOUNDS AS mTOR INHIBITORS

The present invention provides Fused Tricyclic Compounds of the Formula (I) wherein Q, R1, R2, R3, and R4 are as defined herein, and pharmaceutically acceptable salts of such Fused Tricyclic Compounds. The Fused Tricyclic Compounds are useful in the treatment of cancer and other proliferative disord...

Full description

Saved in:
Bibliographic Details
Main Authors REDDY, PANDURANGA, A, SHIPPS, JR., GERALD, W, MENG, ZHAOYANG, CHENG, CLIFF, C, ZENG, HONGBO, DENG, YONGQI, SUN, BINYUAN, LIU, DUAN, ZHAO, LIANYUN, SIDDIQUI, M., ARSHAD, NAN, YANG
Format Patent
LanguageEnglish
French
German
Published 09.05.2012
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides Fused Tricyclic Compounds of the Formula (I) wherein Q, R1, R2, R3, and R4 are as defined herein, and pharmaceutically acceptable salts of such Fused Tricyclic Compounds. The Fused Tricyclic Compounds are useful in the treatment of cancer and other proliferative disorders.
Bibliography:Application Number: EP20100730016